17β-Estradiol enhances the activation of IFN-α signaling in B cells by down-regulating the expression of let-7e-5p, miR-98-5p and miR-145a-5p that target IKKε

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1852, Issue 8, 2015, Pages 1585-1598

  Dong, Guanjun ^a   Fan, Hongye ^a   Yang, Yonghong ^a   Zhao, Guangfeng ^a   You, Ming ^a   Wang, Tingting ^a   Hou, Yayi ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

17 Estradiol; B cells; IFN ; IKK ; MicroRNA

Indexed keywords

ALPHA INTERFERON; ESTRADIOL; I KAPPA B KINASE EPSILON; LET 7E 5P; MICRORNA; MICRORNA 145A 5P; MICRORNA 98 5P; UNCLASSIFIED DRUG; I KAPPA B KINASE; MIRN145 MICRORNA, MOUSE; MIRN98 MICRORNA, MOUSE; MIRNLET7 MICRORNA, MOUSE;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN TARGETING; SEX DIFFERENCE; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; C57BL MOUSE; CASE CONTROL STUDY; CELL CULTURE; DRUG EFFECTS; GENETICS; METABOLISM;

MUS;

ANIMALS; B-LYMPHOCYTES; CASE-CONTROL STUDIES; CELLS, CULTURED; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B KINASE; INTERFERON-ALPHA; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; SIGNAL TRANSDUCTION;

EID: 84928975613     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2015.04.019     Document Type: Article

References (93)

1. Rubtsov A.V., Rubtsova K., Kappler J.W., Marrack P. Genetic and hormonal factors in female-biased autoimmunity. Autoimmun. Rev. 2010, 9:494-498.
2. Gonzalez D.A., Diaz B.B., Rodriguez Perez Mdel C., Hernandez A.G., Chico B.N., de Leon A.C. Sex hormones and autoimmunity. Immunol. Lett. 2010, 133:6-13.
3. Sokka T., Toloza S., Cutolo M., Kautiainen H., Makinen H., Gogus F., Skakic V., Badsha H., Peets T., Baranauskaite A., Geher P., Ujfalussy I., Skopouli F.N., Mavrommati M., Alten R., Pohl C., Sibilia J., Stancati A., Salaffi F., Romanowski W., Zarowny-Wierzbinska D., Henrohn D., Bresnihan B., Minnock P., Knudsen L.S., Jacobs J.W., Calvo-Alen J., Lazovskis J., Pinheiro Gda R., Karateev D., Andersone D., Rexhepi S., Yazici Y., Pincus T. Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res. Ther. 2009, 11:R7.
4. Ansar Ahmed S., Penhale W.J., Talal N. Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am. J. Pathol. 1985, 121:531-551.
5. Schuurs A.H., Verheul H.A. Effects of gender and sex steroids on the immune response. J. Steroid Biochem. 1990, 35:157-172.
6. Hazes J.M., Silman A.J., Brand R., Spector T.D., Walker D.J., Vandenbroucke J.P. Influence of oral contraception on the occurrence of rheumatoid arthritis in female sibs. Scand. J. Rheumatol. 1990, 19:306-310.
7. Roubinian J.R., Talal N., Greenspan J.S., Goodman J.R., Siiteri P.K. Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J. Exp. Med. 1978, 147:1568-1583.
8. Carlsten H., Tarkowski A., Holmdahl R., Nilsson L.A. Oestrogen is a potent disease accelerator in SLE-prone MRL lpr/lpr mice. Clin. Exp. Immunol. 1990, 80:467-473.
9. Verthelyi D., Ahmed S.A. 17 beta-estradiol, but not 5 alpha-dihydrotestosterone, augments antibodies to double-stranded deoxyribonucleic acid in nonautoimmune C57BL/6J mice. Endocrinology 1994, 135:2615-2622.
10. Verthelyi D.I., Ahmed S.A. Estrogen increases the number of plasma cells and enhances their autoantibody production in nonautoimmune C57BL/6 mice. Cell. Immunol. 1998, 189:125-134.
11. Nalbandian G., Kovats S. Understanding sex biases in immunity: effects of estrogen on the differentiation and function of antigen-presenting cells. Immunol. Res. 2005, 31:91-106.
12. Bekesi G., Tulassay Z., Racz K., Feher J., Szekacs B., Kakucs R., Dinya E., Riss E., Magyar Z., Rigo J. The effect of estrogens on superoxide anion generation by human neutrophil granulocytes: possible consequences of the antioxidant defense. Gynecol. Endocrinol. 2007, 23:451-454.
13. Sakiani S., Olsen N.J., Kovacs W.J. Gonadal steroids and humoral immunity. Nat. Rev. Endocrinol. 2013, 9:56-62.
14. Looney R.J., Anolik J.H., Campbell D., Felgar R.E., Young F., Arend L.J., Sloand J.A., Rosenblatt J., Sanz I. B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab. Arthritis Rheum. 2004, 50:2580-2589.
15. Aloisi F., Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat. Rev. Immunol. 2006, 6:205-217.
16. Daridon C., Guerrier T., Devauchelle V., Saraux A., Pers J.O., Youinou P. Polarization of B effector cells in Sjogren's syndrome. Autoimmun. Rev. 2007, 6:427-431.
17. Lipsky P.E. Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat. Immunol. 2001, 2:764-766.
18. Liossis S.N., Kovacs B., Dennis G., Kammer G.M., Tsokos G.C. B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events. J. Clin. Invest. 1996, 98:2549-2557.
19. Kil L.P., Hendriks R.W. Aberrant B cell selection and activation in systemic lupus erythematosus. Int. Rev. Immunol. 2013, 32:445-470.
20. Meyer-Bahlburg A., Rawlings D.J. B cell autonomous TLR signaling and autoimmunity. Autoimmun. Rev. 2008, 7:313-316.
21. Avalos A.M., Busconi L., Marshak-Rothstein A. Regulation of autoreactive B cell responses to endogenous TLR ligands. Autoimmunity 2010, 43:76-83.
22. Scotland R.S., Stables M.J., Madalli S., Watson P., Gilroy D.W. Sex differences in resident immune cell phenotype underlie more efficient acute inflammatory responses in female mice. Blood 2011, 118:5918-5927.
23. Grimaldi C.M., Cleary J., Dagtas A.S., Moussai D., Diamond B. Estrogen alters thresholds for B cell apoptosis and activation. J. Clin. Invest. 2002, 109:1625-1633.
24. Verthelyi D., Ansar Ahmed S. Characterization of estrogen-induced autoantibodies to cardiolipin in non-autoimmune mice. J. Autoimmun. 1997, 10:115-125.
25. Ronnblom L., Alm G.V. Systemic lupus erythematosus and the type I interferon system. Arthritis Res. Ther. 2003, 5:68-75.
26. Kirou K.A., Lee C., George S., Louca K., Peterson M.G., Crow M.K. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum. 2005, 52:1491-1503.
27. Fukuyama S., Kajiwara E., Suzuki N., Miyazaki N., Sadoshima S., Onoyama K. Systemic lupus erythematosus after alpha-interferon therapy for chronic hepatitis C: a case report and review of the literature. Am. J. Gastroenterol. 2000, 95:310-312.
28. Ronnblom L.E., Alm G.V., Oberg K.E. Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour. J. Intern. Med. 1990, 227:207-210.
29. Mathian A., Gallegos M., Pascual V., Banchereau J., Koutouzov S. Interferon-alpha induces unabated production of short-lived plasma cells in pre-autoimmune lupus-prone (NZB×NZW)F1 mice but not in BALB/c mice. Eur. J. Immunol. 2011, 41:863-872.
30. Thien M., Phan T.G., Gardam S., Amesbury M., Basten A., Mackay F., Brink R. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 2004, 20:785-798.
31. Bekeredjian-Ding I.B., Wagner M., Hornung V., Giese T., Schnurr M., Endres S., Hartmann G. Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN. J. Immunol. 2005, 174:4043-4050.
32. Uccellini M.B., Busconi L., Green N.M., Busto P., Christensen S.R., Shlomchik M.J., Marshak-Rothstein A., Viglianti G.A. Autoreactive B cells discriminate CpG-rich and CpG-poor DNA and this response is modulated by IFN-alpha. J. Immunol. 2008, 181:5875-5884.
33. Braun D., Caramalho I., Demengeot J. IFN-alpha/beta enhances BCR-dependent B cell responses. Int. Immunol. 2002, 14:411-419.
34. Douagi I., Gujer C., Sundling C., Adams W.C., Smed-Sorensen A., Seder R.A., Karlsson Hedestam G.B., Lore K. Human B cell responses to TLR ligands are differentially modulated by myeloid and plasmacytoid dendritic cells. J. Immunol. 2009, 182:1991-2001.
35. Becker A.M., Dao K.H., Han B.K., Kornu R., Lakhanpal S., Mobley A.B., Li Q.Z., Lian Y., Wu T., Reimold A.M., Olsen N.J., Karp D.R., Chowdhury F.Z., Farrar J.D., Satterthwaite A.B., Mohan C., Lipsky P.E., Wakeland E.K., Davis L.S. SLE peripheral blood B cell, T cell and myeloid cell transcriptomes display unique profiles and each subset contributes to the interferon signature. PLoS One 2013, 8:e67003.
36. Baechler E.C., Batliwalla F.M., Karypis G., Gaffney P.M., Ortmann W.A., Espe K.J., Shark K.B., Grande W.J., Hughes K.M., Kapur V., Gregersen P.K., Behrens T.W. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:2610-2615.
37. Panchanathan R., Shen H., Bupp M.G., Gould K.A., Choubey D. Female and male sex hormones differentially regulate expression of Ifi202, an interferon-inducible lupus susceptibility gene within the Nba2 interval. J. Immunol. 2009, 183:7031-7038.
38. Tsokos G.C. Systemic lupus erythematosus. N. Engl. J. Med. 2011, 365:2110-2121.
39. Banchereau J., Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 2006, 25:383-392.
40. Feng X., Wu H., Grossman J.M., Hanvivadhanakul P., FitzGerald J.D., Park G.S., Dong X., Chen W., Kim M.H., Weng H.H., Furst D.E., Gorn A., McMahon M., Taylor M., Brahn E., Hahn B.H., Tsao B.P. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus. Arthritis Rheum. 2006, 54:2951-2962.
41. Choubey D., Panchanathan R., Duan X., Liu H. Emerging roles for the interferon-inducible p200-family proteins in sex bias in systemic lupus erythematosus. J. Interferon Cytokine Res. 2011, 31:893-906.
42. Choubey D., Panchanathan R. Interferon-inducible Ifi200-family genes in systemic lupus erythematosus. Immunol. Lett. 2008, 119:32-41.
43. Meier A., Chang J.J., Chan E.S., Pollard R.B., Sidhu H.K., Kulkarni S., Wen T.F., Lindsay R.J., Orellana L., Mildvan D., Bazner S., Streeck H., Alter G., Lifson J.D., Carrington M., Bosch R.J., Robbins G.K., Altfeld M. Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat. Med. 2009, 15:955-959.
44. Seillet C., Laffont S., Tremollieres F., Rouquie N., Ribot C., Arnal J.F., Douin-Echinard V., Gourdy P., Guery J.C. The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor alpha signaling. Blood 2012, 119:454-464.
45. Ng S.L., Friedman B.A., Schmid S., Gertz J., Myers R.M., Tenoever B.R., Maniatis T. IkappaB kinase epsilon (IKK(epsilon)) regulates the balance between type I and type II interferon responses. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:21170-21175.
46. Wang C., Ahlford A., Laxman N., Nordmark G., Eloranta M.L., Gunnarsson I., Svenungsson E., Padyukov L., Sturfelt G., Jonsen A., Bengtsson A.A., Truedsson L., Rantapaa-Dahlqvist S., Sjowall C., Sandling J.K., Ronnblom L., Syvanen A.C. Contribution of IKBKE and IFIH1 gene variants to SLE susceptibility. Genes Immun. 2013, 14:217-222.
47. Sandling J.K., Garnier S., Sigurdsson S., Wang C., Nordmark G., Gunnarsson I., Svenungsson E., Padyukov L., Sturfelt G., Jonsen A., Bengtsson A.A., Truedsson L., Eriksson C., Rantapaa-Dahlqvist S., Malarstig A., Strawbridge R.J., Hamsten A., Criswell L.A., Graham R.R., Behrens T.W., Eloranta M.L., Alm G., Ronnblom L., Syvanen A.C. A candidate gene study of the type I interferon pathway implicates IKBKE and IL8 as risk loci for SLE. Eur. J. Hum. Genet. 2011, 19:479-484.
48. Dai R., Phillips R.A., Zhang Y., Khan D., Crasta O., Ahmed S.A. Suppression of LPS-induced interferon-gamma and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: a novel mechanism of immune modulation. Blood 2008, 112:4591-4597.
49. Taganov K.D., Boldin M.P., Baltimore D. MicroRNAs and immunity: tiny players in a big field. Immunity 2007, 26:133-137.
50. Shen N., Liang D., Tang Y., de Vries N., Tak P.P. MicroRNAs-novel regulators of systemic lupus erythematosus pathogenesis. Nat. Rev. Rheumatol. 2012, 8:701-709.
51. Pauley K.M., Cha S., Chan E.K. MicroRNA in autoimmunity and autoimmune diseases. J. Autoimmun. 2009, 32:189-194.
52. Mishima T., Takizawa T., Luo S.S., Ishibashi O., Kawahigashi Y., Mizuguchi Y., Ishikawa T., Mori M., Kanda T., Goto T. MicroRNA (miRNA) cloning analysis reveals sex differences in miRNA expression profiles between adult mouse testis and ovary. Reproduction 2008, 136:811-822.
53. Cheung L., Gustavsson C., Norstedt G., Tollet-Egnell P. Sex-different and growth hormone-regulated expression of microRNA in rat liver. BMC Mol. Biol. 2009, 10:13.
54. Cohen A., Smith Y. Estrogen regulation of microRNAs, target genes, and microRNA expression associated with vitellogenesis in the zebrafish. Zebrafish 2014, 11:462-478.
55. Bhat-Nakshatri P., Wang G., Collins N.R., Thomson M.J., Geistlinger T.R., Carroll J.S., Brown M., Hammond S., Srour E.F., Liu Y., Nakshatri H. Estradiol-regulated microRNAs control estradiol response in breast cancer cells. Nucleic Acids Res. 2009, 37:4850-4861.
56. Fan H., Dong G., Zhao G., Liu F., Yao G., Zhu Y., Hou Y. Gender differences of B cell signature in healthy subjects underlie disparities in incidence and course of SLE related to estrogen. J. Immunol. Res. 2014, 2014:814598.
57. Zhao X., Liu D., Gong W., Zhao G., Liu L., Yang L., Hou Y. The toll-like receptor 3 ligand, poly(I:C), improves immunosuppressive function and therapeutic effect of mesenchymal stem cells on sepsis via inhibiting MiR-143. Stem Cells 2014, 32:521-533.
58. Rawlings D.J., Schwartz M.A., Jackson S.W., Meyer-Bahlburg A. Integration of B cell responses through Toll-like receptors and antigen receptors. Nat. Rev. Immunol. 2012, 12:282-294.
59. Clingan J.M., Matloubian M. B cell-intrinsic TLR7 signaling is required for optimal B cell responses during chronic viral infection. J. Immunol. 2013, 191:810-818.
60. Samarajiwa S.A., Forster S., Auchettl K., Hertzog P.J. INTERFEROME: the database of interferon regulated genes. Nucleic Acids Res. 2009, 37:D852-D857.
61. Miettinen M., Sareneva T., Julkunen I., Matikainen S. IFNs activate toll-like receptor gene expression in viral infections. Genes Immun. 2001, 2:349-355.
62. Tissari J., Siren J., Meri S., Julkunen I., Matikainen S. IFN-alpha enhances TLR3-mediated antiviral cytokine expression in human endothelial and epithelial cells by up-regulating TLR3 expression. J. Immunol. 2005, 174:4289-4294.
63. Agarwal S.K., Wu M., Livingston C.K., Parks D.H., Mayes M.D., Arnett F.C., Tan F.K. Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblasts. Arthritis Res. Ther. 2011, 13:R3.
64. Thibault D.L., Graham K.L., Lee L.Y., Balboni I., Hertzog P.J., Utz P.J. Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus. Arthritis Res. Ther. 2009, 11:R112.
65. Giordani L., Sanchez M., Libri I., Quaranta M.G., Mattioli B., Viora M. IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production. J. Leukoc. Biol. 2009, 86:261-271.
66. Dai R., Phillips R.A., Karpuzoglu E., Khan D., Ahmed S.A. Estrogen regulates transcription factors STAT-1 and NF-kappaB to promote inducible nitric oxide synthase and inflammatory responses. J. Immunol. 2009, 183:6998-7005.
67. Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E., Golenbock D.T., Coyle A.J., Liao S.M., Maniatis T. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 2003, 4:491-496.
68. Sharma S., tenOever B.R., Grandvaux N., Zhou G.P., Lin R., Hiscott J. Triggering the interferon antiviral response through an IKK-related pathway. Science 2003, 300:1148-1151.
69. Maniatis T., Falvo J.V., Kim T.H., Kim T.K., Lin C.H., Parekh B.S., Wathelet M.G. Structure and function of the interferon-beta enhanceosome. Cold Spring Harb. Symp. Quant. Biol. 1998, 63:609-620.
70. Adrie C., Azoulay E., Francais A., Clec'h C., Darques L., Schwebel C., Nakache D., Jamali S., Goldgran-Toledano D., Garrouste-Orgeas M., Timsit J.F. Influence of gender on the outcome of severe sepsis: a reappraisal. Chest 2007, 132:1786-1793.
71. Marriott I., Huet-Hudson Y.M. Sexual dimorphism in innate immune responses to infectious organisms. Immunol. Res. 2006, 34:177-192.
72. Guan H., Fan D., Mrelashvili D., Hao H., Singh N.P., Singh U.P., Nagarkatti P.S., Nagarkatti M. MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis. Eur. J. Immunol. 2013, 43:104-114.
73. Liu Y., Chen Q., Song Y., Lai L., Wang J., Yu H., Cao X., Wang Q. MicroRNA-98 negatively regulates IL-10 production and endotoxin tolerance in macrophages after LPS stimulation. FEBS Lett. 2011, 585:1963-1968.
74. Wang S., Tang Y., Cui H., Zhao X., Luo X., Pan W., Huang X., Shen N. Let-7/miR-98 regulate Fas and Fas-mediated apoptosis. Genes Immun. 2011, 12:149-154.
75. Lu M.C., Lai N.S., Chen H.C., Yu H.C., Huang K.Y., Tung C.H., Huang H.B., Yu C.L. Decreased microRNA(miR)-145 and increased miR-224 expression in T cells from patients with systemic lupus erythematosus involved in lupus immunopathogenesis. Clin. Exp. Immunol. 2013, 171:91-99.
76. Baek D., Villen J., Shin C., Camargo F.D., Gygi S.P., Bartel D.P. The impact of microRNAs on protein output. Nature 2008, 455:64-71.
77. Olsen P.H., Ambros V. The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev. Biol. 1999, 216:671-680.
78. Guo H., Ingolia N.T., Weissman J.S., Bartel D.P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010, 466:835-840.
79. Vasudevan S., Tong Y., Steitz J.A. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007, 318:1931-1934.
80. Ascenzi P., Bocedi A., Marino M. Structure-function relationship of estrogen receptor alpha and beta: impact on human health. Mol. Aspects Med. 2006, 27:299-402.
81. Calippe B., Douin-Echinard V., Delpy L., Laffargue M., Lelu K., Krust A., Pipy B., Bayard F., Arnal J.F., Guery J.C., Gourdy P. 17Beta-estradiol promotes TLR4-triggered proinflammatory mediator production through direct estrogen receptor alpha signaling in macrophages in vivo. J. Immunol. 2010, 185:1169-1176.
82. Bynote K.K., Hackenberg J.M., Korach K.S., Lubahn D.B., Lane P.H., Gould K.A. Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB×NZW)F1 mice. Genes Immun. 2008, 9:137-152.
83. Castellano L., Giamas G., Jacob J., Coombes R.C., Lucchesi W., Thiruchelvam P., Barton G., Jiao L.R., Wait R., Waxman J., Hannon G.J., Stebbing J. The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:15732-15737.
84. Mendelsohn M.E., Karas R.H. Rapid progress for non-nuclear estrogen receptor signaling. J. Clin. Invest. 2010, 120:2277-2279.
85. Pierdominici M., Maselli A., Colasanti T., Giammarioli A.M., Delunardo F., Vacirca D., Sanchez M., Giovannetti A., Malorni W., Ortona E. Estrogen receptor profiles in human peripheral blood lymphocytes. Immunol. Lett. 2010, 132:79-85.
86. Colasanti T., Maselli A., Conti F., Sanchez M., Alessandri C., Barbati C., Vacirca D., Tinari A., Chiarotti F., Giovannetti A., Franconi F., Valesini G., Malorni W., Pierdominici M., Ortona E. Autoantibodies to estrogen receptor alpha interfere with T lymphocyte homeostasis and are associated with disease activity in systemic lupus erythematosus. Arthritis Rheum. 2012, 64:778-787.
87. Kovats S., Carreras E. Regulation of dendritic cell differentiation and function by estrogen receptor ligands. Cell. Immunol. 2008, 252:81-90.
88. Zwijsen R.M., Wientjens E., Klompmaker R., van der Sman J., Bernards R., Michalides R.J. CDK-independent activation of estrogen receptor by cyclin D1. Cell 1997, 88:405-415.
89. Moulton V.R., Holcomb D.R., Zajdel M.C., Tsokos G.C. Estrogen upregulates cyclic AMP response element modulator alpha expression and downregulates interleukin-2 production by human T lymphocytes. Mol. Med. 2012, 18:370-378.
90. Liu Z., Davidson A. Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat. Med. 2012, 18:871-882.
91. von Muhlen C.A., Tan E.M. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin. Arthritis Rheum. 1995, 24:323-358.
92. Jeganathan V., Peeva E., Diamond B. Hormonal milieu at time of B cell activation controls duration of autoantibody response. J. Autoimmun. 2014, 53:46-54.
93. Takaoka A., Yanai H. Interferon signalling network in innate defence. Cell. Microbiol. 2006, 8:907-922.